TWEAK, a New Biomarker for Predicting Inflammatory Relapses in Multiple Sclerosis
TWEAK, a New Biomarker for Predicting Inflammatory Relapses in Multiple Sclerosis
Recruiting · NCT03974997 · Registry updated 2026-09-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| TWEAK, a New Biomarker for Predicting Inflammatory Relapses in Multiple Sclerosis | CNS demyelinating autoimmune disease, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder | Recruiting | Not applicable | 2026-09-23 | NCT03974997 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Assistance Publique Hopitaux De Marseille | 131 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Assistance Publique Hopitaux de Marseille | Marseille | France | 6 |